Clinical Trial Update: Efficacy and Safety of Empagliflozin in GSD-Ib Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy and safety of empagliflozin in Glycogen Storage Disease Type Ib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glycogen Storage Disease Type Ib

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Glycogen Storage Disease Type IB | Phase 2 | Status: UNKNOWN